Skip to content

Envoy Medical COCH Issuance of warrants

Issuance of warrants at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$2.52M-75.7%
Ispire Technology Inc. logo
Ispire Technology Inc.ISPR
$91.49K
SVC
Stellar V Capital Corp. Class A Ordinary SharesSVCC
$1.22M
Evommune
 logo
Evommune EVMN
$150
CO2 Energy Transition Corp. Common Stock logo
CO2 Energy Transition Corp. Common StockNOEM
$51.75K
ADMA Biologics logo
ADMA BiologicsADMA
$1.4M

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: Envoy Medical’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's issuance of warrants?
Envoy Medical (COCH) reported issuance of warrants of $882K in Q2 2025.
How has Envoy Medical's issuance of warrants changed year-over-year?
Envoy Medical's issuance of warrants increased by 347.7% year-over-year, from $197K to $882K.
What does issuance of warrants mean?
The total value assigned to warrants issued by the company, recorded as an adjustment to additional paid-in capital. This reflects the capital structure impact of using warrants as a financing or incentive tool.